Oculomucocutaneous syndrome

From WikiMD's WELLNESSPEDIA


Oculomucocutaneous syndrome
Synonyms Stevens-Johnson syndrome, Lyell's syndrome
Pronounce N/A
Specialty N/A
Symptoms Conjunctivitis, keratitis, skin rash, oral ulcers
Complications Blindness, scarring, infection
Onset Sudden
Duration Variable
Types N/A
Causes Adverse drug reaction, infection
Risks Medication use, viral infections
Diagnosis Clinical examination, biopsy
Differential diagnosis Pemphigus vulgaris, toxic epidermal necrolysis
Prevention N/A
Treatment Corticosteroids, supportive care
Medication Antibiotics, analgesics
Prognosis Variable, can be severe
Frequency Rare
Deaths N/A


Oculomucocutaneous syndrome is a rare medical condition that affects the eyes, mucous membranes, and skin. It is often associated with the use of certain medications, particularly the drug practolol, a beta-blocker used to treat high blood pressure and heart conditions.

Symptoms[edit]

The symptoms of oculomucocutaneous syndrome can vary widely, but often include:

Causes[edit]

Oculomucocutaneous syndrome is most commonly associated with the use of the drug practolol. However, it can also occur as a result of other medications or underlying health conditions.

Diagnosis[edit]

Diagnosis of oculomucocutaneous syndrome is typically based on the presence of characteristic symptoms and a history of exposure to certain medications. Additional tests, such as a skin biopsy, may be performed to confirm the diagnosis.

Treatment[edit]

Treatment for oculomucocutaneous syndrome typically involves discontinuing the medication that is causing the condition. Additional treatments, such as topical steroids or artificial tears, may be used to manage symptoms.

See also[edit]

References[edit]